Human sTfR Quantikine IVD ELISA Kit
| Name | Human sTfR Quantikine IVD ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DTFR1 |
| Category | ELISA Kit |
| Prices | $509.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Serum (20 uL), EDTA Plasma (20 uL), Heparin Plasma (20 uL), Citrate Plasma (20 uL) |
| Sensitivity | 0.5 nmol/L |
| Range | 3.0 - 80 nmol/L (Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine IVD Human sTfR Immunoassay is designed for the quantitative determination of soluble transferrin receptor (sTfR) concentrations in human serum and plasma as an aid in the diagnosis of Iron-Deficiency Anemia (IDA), especially for the differential diagnosis of IDA and Anemia of Chronic Disease (ACD) |
| Gene | TFRC |
| Supplier Page | Shop |
Product images
_DTFR1_ELISA_191.jpg)
Product References
The impact of maternal obesity on iron status, placental transferrin receptor - The impact of maternal obesity on iron status, placental transferrin receptor
Garcia-Valdes L, Campoy C, Hayes H, Florido J, Rusanova I, Miranda MT, McArdle HJ. Int J Obes (Lond). 2015 Apr;39(4):571-8.
Host iron redistribution as a risk factor for incident tuberculosis in HIV - Host iron redistribution as a risk factor for incident tuberculosis in HIV
McDermid JM, Hennig BJ, van der Sande M, Hill AV, Whittle HC, Jaye A, Prentice AM. BMC Infect Dis. 2013 Jan 29;13:48.
Regulation of hepcidin expression at high altitude. - Regulation of hepcidin expression at high altitude.
Talbot NP, Lakhal S, Smith TG, Privat C, Nickol AH, Rivera-Ch M, Leon-Velarde F, Dorrington KL, Mole DR, Robbins PA. Blood. 2012 Jan 19;119(3):857-60.
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans - Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans
Piperno A, Galimberti S, Mariani R, Pelucchi S, Ravasi G, Lombardi C, Bilo G, Revera M, Giuliano A, Faini A, Mainini V, Westerman M, Ganz T, Valsecchi MG, Mancia G, Parati G. Blood. 2011 Mar 10;117(10):2953-9.
Comparison between one and three doses a week of recombinant erythropoietin in - Comparison between one and three doses a week of recombinant erythropoietin in
Vazquez Lopez MA, Llamas MA, Galera R, Sanchez AR, Lendinez F, Gonzalez-Ripoll M, Diez J, Bonillo A. J Perinatol. 2011 Feb;31(2):118-24.
Randomized, double-blind, placebo-controlled trial of an iron-fortified food - Randomized, double-blind, placebo-controlled trial of an iron-fortified food
Karl JP, Lieberman HR, Cable SJ, Williams KW, Young AJ, McClung JP. Am J Clin Nutr. 2010 Jul;92(1):93-100.
Time course of anemia during six months follow up following intensive care - Time course of anemia during six months follow up following intensive care
Bateman AP, McArdle F, Walsh TS. Crit Care Med. 2009 Jun;37(6):1906-12.
Body iron excretion by healthy men and women. - Body iron excretion by healthy men and women.
Hunt JR, Zito CA, Johnson LK. Am J Clin Nutr. 2009 Jun;89(6):1792-8.
Randomized, double-blind, placebo-controlled trial of iron supplementation in - Randomized, double-blind, placebo-controlled trial of iron supplementation in
McClung JP, Karl JP, Cable SJ, Williams KW, Nindl BC, Young AJ, Lieberman HR. Am J Clin Nutr. 2009 Jul;90(1):124-31.
Mortality in HIV infection is independently predicted by host iron status and - Mortality in HIV infection is independently predicted by host iron status and
McDermid JM, van der Loeff MF, Jaye A, Hennig BJ, Bates C, Todd J, Sirugo G, Hill AV, Whittle HC, Prentice AM. Am J Clin Nutr. 2009 Jul;90(1):225-33.